ENO

Eno is the most global of GlaxoSmithKline's (GSK) gastrointestinal products. The fastacting effervescent fruit salts, used as an antacid and reliever of belatedness, was invented in the 1850s by James Crossley Eno (1827-1915). It has sales of nearly 30 million; its major markets are Spain, India, Brazil, South Africa, Malaysia and Thailand. It is frequently used as a substitute for baking powder. Eno Tagline: "Gets to work in 6 seconds" Its USP - Helps relieves the symptoms and discomfort caused by excess acidity such as indigestion, nausea and flatulence

S.T.P SEGMENT-Antacid medicine

TARGET- Antacid medicine

POSITIONING- A range of antacid products that treat the symptoms of heartburn and gastric discomfort

SWOT Analysis
Strength
1.

Very well accepted in the market and enjoys the trust associated with GSK brand. 2. Strong brand recall worldwide.

3. Available in different flavor and pack formats, recently launched cola flavor with aggressive promotion. 4. Suitable for diabetes patients also due to low sugar content 5. Good advertising and visibility through TVCs

Weakness
1. No innovations and changes have been 2. Not recommended for people on a salt restricted diet introduced in the brand.

3. May not be suitable to some people with liver, kidney problems

Opportunity
1.With the kind of food habits developing and increased dependency on fast food, people frequently suffer from indigestion and demand for such remedies would rise 2. The segment is characterized by a small number of players and low penetration. 3. The brand can target youth also since with the kind of stress and hectic lifestyles, they also suffer from such problems and can start using the product

Threats
1.People have started preferring Ayurvedic and natural medications for relief from daily gastrointestinal ailments. 2. Lot of competition in the market with people mostly relying on doctors prescriptions.

Competitors
1.KayamChurna 2. Digene